FdaApplication
ANDA 208170
Identifiers
- fda_app_no: ANDA208170
Properties
| Property | Value |
|---|---|
| applicant_name | RUBICON RESEARCH LTD |
| application_type | ANDA |
| approval_date | 2017-05-31 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | 10MG | TABLET;ORAL |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | 5MG | TABLET;ORAL |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | 7.5MG | TABLET;ORAL |
3 products